{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:18:02Z","timestamp":1790093882120,"version":"4.0.1"},"reference-count":40,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":141,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:p><jats:bold>BACKGROUND<\/jats:bold> Hypopituitarism in adults is associated with increased vascular mortality, which has been attributed to GH deficiency.<\/jats:p><jats:p><jats:bold>OBJECTIVE<\/jats:bold> To compare the lipid profile and coronary risk predicted by the Framingham Heart Study equation in GH\u2010deficient hypopituitary patients and healthy age and gender\u2010matched controls.<\/jats:p><jats:p><jats:bold>DESIGN<\/jats:bold> A cross\u2010sectional observational study.<\/jats:p><jats:p><jats:bold>METHODS<\/jats:bold> We studied 50 adult\u2010onset growth hormone deficient hypopituitary patients (23F, 27M), on appropriate conventional hormone replacement and 45 controls (22F, 23M) matched for age, gender and smoking habit. The subjects (age range 30\u201375\u2003years) were free from diabetes, hypertension, ischaemic heart disease (IHD) and peripheral vascular disease. All hypogonadal male patients were on testosterone replacement therapy. A similar proportion of female patients (8\/23) and controls (7\/22) were on HRT. Body mass index (BMI), waist\u2013hip ratio (WHR) and blood pressure were recorded. After an overnight fast blood\u00a0glucose, total\u2010cholesterol, triglycerides, HDL\u2010cholesterol, apolipoproteins A\u2010I, B and Lp (a) were measured. Coronary risk was calculated for each individual from age, gender, systolic blood pressure, total and HDL cholesterol, smoking habit and presence of diabetes and left ventricular hypertrophy using the Framingham equation.<\/jats:p><jats:p><jats:bold>RESULTS<\/jats:bold> BMI and WHR were significantly increased in GHD hypopituitary adults of both sexes, but to a greater extent in females. Triglycerides were elevated\u00a0in both sexes. Total and LDL\u2010cholesterol were increased in both sexes (significantly only in males), and HDL cholesterol and apo A\u2010I were lower (significantly only in females). The reduction in HDL\u00a0cholesterol was correlated negatively with adiposity (BMI), particularly when centrally distributed (WHR) in patients and controls. LDL cholesterol did not correlate to adiposity but higher levels were\u00a0present in GH\u2010deficient subjects. The total to HDL cholesterol ratio was significantly increased in patients of both genders (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7002). There were no differences in the apolipoproteins B and Lp(a) between patients\u00a0and controls. Absolute risk (mean \u00b1\u200aSEM) of a fatal or\u00a0non\u2010fatal coronary event during the next\u00a05\u2003years was significantly greater in GHD hypopituitary patients than control subjects (4\u00b782\u2003\u00b1\u20030\u00b773% <jats:italic>vs.<\/jats:italic> 2\u00b794\u2003\u00b1\u20030\u00b753, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b704). Cardiovascular risk relative to the local population (RR) was significantly higher in GHD hypopituitary adults (RR\u2003=\u20031\u00b743\u2003CL 1\u00b706\u20131\u00b780, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7011) but not in the control group (1\u00b708\u2003CL 0\u00b759\u20131\u00b76). When divided by gender, RR for male patients was not increased (1\u00b714\u2003CL 0\u00b783\u20131\u00b745, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7096). However, female patients had significantly higher RR (1\u00b77\u2003CL 1\u00b705\u20132\u00b75, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7048). The RR for male and female\u00a0controls was not different from the local population.<\/jats:p><jats:p><jats:bold>CONCLUSION<\/jats:bold> Changes in lipid levels help to explain the results from risk factor modelling which show increased coronary risk in growth hormone deficient hypopituitary patients, particularly females. The abnormal lipid profile is characterized in both genders by an increase in the total to HDL cholesterol ratio, an important parameter in the Framingham equation, and is related to growth hormone deficiency either directly (LDL) or indirectly. The lipid abnormalities conferring increased risk appear to be through increased central obesity (HDL). Adverse calculated coronary risk might provide a new objective indication for consideration of GH replacement therapy in adults.<\/jats:p>","DOI":"10.1046\/j.1365-2265.2001.01320.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:50:20Z","timestamp":1047379820000},"page":"209-216","source":"Crossref","is-referenced-by-count":84,"title":["Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities"],"prefix":"10.1111","volume":"55","author":[{"given":"Tarig A. M.","family":"Abdu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Neary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik A.","family":"Elhadd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Akber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"28","article-title":"Insulin sensitivity in growth hormone (GH)\u2010deficient adults and effect of GH replacement therapy","volume":"22","author":"Alford F.P.","year":"1999","journal-title":"Journal of Endocrinological Investigation"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.8.2653"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90861-B"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(84)90124-0"},{"key":"e_1_2_6_6_1","first-page":"8","article-title":"The emergence of triglycerides as a significant independent risk factor in coronary artery disease","volume":"19","author":"Assmann G.","year":"1998","journal-title":"European Heart Journal"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00650.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.3.1169"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01860.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.2.356"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00682.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02287.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(82)90121-4"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/jcem.82.5.3951","article-title":"Increased arterial intima\u2010media thickness in childhood\u2010onset growth hormone deficiency","volume":"82","author":"Capaldo B.","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-8703(86)90296-6","article-title":"The triglyceride issue: a review from Framingham","volume":"256","author":"Castelli W.P.","year":"1986","journal-title":"American Heart Journal"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90145-E"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.13.2.296"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge","volume":"18","author":"Freidewald W.T.","year":"1972","journal-title":"Clinical Chemistry"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043798-199604000-00014"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-351X(87)80029-0"},{"key":"e_1_2_6_22_1","first-page":"1","volume-title":"Health Care Needs Assessment: coronary heart disease","author":"Langham S.","year":"1997"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00597.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92664-F"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1360157"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92892-J"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1054\/ghir.1999.0102"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.4.832"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.2.453"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7236.676"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91812-O"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00974.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00473.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02555.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912283212605"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800618"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00772.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9150(97)00110-x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.3.312"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01797616"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(95)05673-4"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.2001.01320.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.2001.01320.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.2001.01320.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T23:48:37Z","timestamp":1695858517000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.2001.01320.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1046\/j.1365-2265.2001.01320.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01320.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}